New regulatory changes in pharma and healthcare: Q1 2025 Legal Overview

The beginning of 2025 brought updates to legislation affecting the pharmaceutical and healthcare sectors in Belarus and across the EAEU. REVERA Belarus team has compiled a comprehensive Q1 2025 Legal Overview, highlighting the most critical regulatory changes businesses need to know.

Among the topics covered:

• New EAEU rules for drug and biological product registration;
• Updated requirements for patient information leaflets;
• Changes in laboratory and diagnostic service regulation;
• Restrictions on iron supplement advertising;
• Concepts for unified markets of medicines and medical devices.